Kario, Kazuomi
Hasebe, Naoyuki
Okumura, Ken
Yamashita, Takeshi
Akao, Masaharu
Atarashi, Hirotsugu
Ikeda, Takanori
Koretsune, Yukihiro
Shimizu, Wataru
Suzuki, Shinya
Tsutsui, Hiroyuki
Toyoda, Kazunori
Hirayama, Atsushi
Yasaka, Masahiro
Yamaguchi, Takenori
Teramukai, Satoshi
Kimura, Tetsuya
Morishima, Yoshiyuki
Takita, Atsushi
Inoue, Hiroshi
Article History
Received: 3 February 2023
Revised: 10 May 2023
Accepted: 16 June 2023
First Online: 11 July 2023
Compliance with ethical standards
:
: Dr KK received research grants from Bristol Myers Squibb, Bayer, Daiichi Sankyo, Omron Healthcare Inc., and A&D Inc, and remuneration from Daiichi Sankyo, Bayer, and Omron Healthcare Inc. Dr NH received research funding from Bristol Myers Squibb and Daiichi Sankyo, and remuneration from Daiichi Sankyo and Bayer. Dr KO received remuneration from Nippon Boehringer Ingelheim, Daiichi Sankyo, Johnson & Johnson, and Medtronic. Dr TY received research funding from Bristol Myers Squibb, Bayer, and Daiichi Sankyo, manuscript fees from Daiichi Sankyo and Bristol Myers Squibb, and remuneration from Daiichi Sankyo, Bayer, Pfizer Japan, and Bristol Myers Squibb. Dr MA received research funding from Bayer and Daiichi Sankyo, and remuneration from Bristol Myers Squibb, Nippon Boehringer Ingelheim, Bayer, and Daiichi Sankyo. Dr HA received remuneration from Daiichi Sankyo. Dr TI received research funding from Daiichi Sankyo and Bayer, and remuneration from Daiichi Sankyo, Bayer, Nippon Boehringer Ingelheim, and Bristol Myers Squibb. Dr YK received remuneration from Daiichi Sankyo, Bayer, and Nippon Boehringer Ingelheim. Dr WS received research funding from Bristol Myers Squibb, Daiichi Sankyo, and Nippon Boehringer Ingelheim, and patent royalties/licensing fees from Daiichi Sankyo, Pfizer Japan, Bristol Myers Squibb, Bayer, and Nippon Boehringer Ingelheim. Dr SS received research funding from Mitsubishi-Tanabe and Daiichi Sankyo, and remuneration from Bristol Myers Squibb and Daiichi Sankyo. Dr HT received research funding from Daiichi Sankyo and Nippon Boehringer Ingelheim, remuneration from Daiichi Sankyo, Bayer, Nippon Boehringer Ingelheim, and Pfizer Japan, scholarship funding from Daiichi Sankyo, and consultancy fees from Pfizer Japan, Bayer, and Nippon Boehringer Ingelheim. Dr KT received lecture honoraria from Daiichi Sankyo, Otsuka, Novartis, Abbott, Bayer Yakuhin, and Bristol Myers Squibb outside the submitted work. Dr AH participated in a course endowed by Boston Scientific Japan, has received research funding from Daiichi Sankyo and Bayer, and remuneration from Bayer, Daiichi Sankyo, Bristol Myers Squibb, and Nippon Boehringer Ingelheim. Dr MY received research funding from Nippon Boehringer Ingelheim, and remuneration from Nippon Boehringer Ingelheim, Daiichi Sankyo, Bayer, Bristol Myers Squibb, and Pfizer Japan. Dr TY acted as an Advisory Board member of Daiichi Sankyo and received remuneration from Daiichi Sankyo and Bristol Myers Squibb. Dr ST received research funding from Nippon Boehringer Ingelheim and remuneration from Daiichi Sankyo, Sanofi, Takeda, Chugai Pharmaceutical, Solasia Pharma, Bayer, Sysmex, Nipro, NapaJen Pharma, Gunze, Kaneka, Kringle Pharma and Atworking. TK, Dr YM, and AT are employees of Daiichi Sankyo. Dr HI received remuneration from Daiichi Sankyo, Bristol Myers Squibb, and Nippon Boehringer Ingelheim.